On July 28, 2006, Siskinds filed a class proceeding against Janssen-Ortho Inc. with respect to the contraceptive patch Evra. Use of Evra has been associated with an increased risk of developing blood clots, pulmonary emboli, strokes, heart attacks and/or deep vein thrombosis.
The Defendant has now settled certain individual claims, including that of the proposed representative plaintiff. As a result, the action will no longer be pursued on a class-wide basis and on March 23, 2009 the class proceeding was discontinued.